SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " testing " 965 found 🔀 AI-powered Shuffle
Sixth in Kona: Sam Long's Performance and the Science Behind the Build
How metabolic testing helped inform the training, pacing, and fueling decisions behind a sixth-place Ironman World Championship finish.
Microsoft Says Its New AI Is More Than Twice as Good at Diagnosing Diseases as Doctors
Microsoft plans to start testing the tool in a Boston hospital soon.
U.K. politicians are testing their messages on AI-generated focus groups
Firms are using data from real focus groups and surveys to build AI personas able to react to political messages within minutes.
iPhone Duo 2 Prototypes Include Under-Display Face ID
Apple's second-generation iPhone Duo could gain Face ID, with prototypes already incorporating the technology beneath the outer display, according to Bloomberg's Mark Gurman. In the latest episode of his "Power On" podcast, Gurman described Apple's work on adding facial authentication technology to its foldable iPhone. The company is said to be testing the hardware for a successor expected next fall, but has not finalized whether the feature will ship.
YouTube says it isn’t testing hiding the dislike button
The dislike button is staying put, for the most part.
Does the iPhone Duo Run Hot? Here's What Reviews Found
Multiple iPhone Duo reviews covered the device's thermal properties, and reviewer opinions varied. Some found that it was just warm, while others thought it was running too hot at times. Joanna Stern said the back of the device got warm when using FaceTime and taking photos. She had to end a FaceTime call during testing because it got too hot. "Yeah, I'm gonna burn my hand off," she said. "This thing is getting really warm".
Oracle AI Agent Studio for Industry Applications Helps Accelerate Business Outcomes
/PRNewswire/ -- Oracle today announced Oracle AI Agent Studio1 for Industry Applications, a no-code and low-code environment for creating, testing,...
Computer science student takes engineering skills to Neuralink
A challenging classroom project helped Mateo McKee land an internship developing software that supports the manufacturing and testing of Neuralink’s brain implants.
Sundar Pichai: Google’s Frontier Imperative, Compute Scarcity Dilemmas, Future AI Products and Businesses
Alphabet CEO Sundar Pichai has little patience for doubts about Google’s willingness or capacity to compete at the frontier of AI. His company’s latest Gemini 4 Argon model — long-promised and recently delivered — beats OpenAI and Anthropic’s latest public models on coding, math, science, and knowledge-work benchmarks and has placed Google’s AI back among the world’s best. Amid chatter that Google was fine with good-enough lightweight ‘Flash’ models, Pichai pushed back hard against any suggestion that company is limiting its research ambitions. “We won’t do it any other way,” he told me in a Big Technology Podcast interview recorded this week at Google’s Mountain View headquarters. Pursuing cutting-edge research is costly for Google, requiring compute and chips that otherwise could be sold at a high markup by its cloud business. But Pichai said allocating resources to frontier AI development is “ground zero” for Google. “Our cloud business is at any given moment in time forgoing short-term revenues because we are making compute trade-offs to support frontier AI development,” Pichai told me. In our conversation, we discussed Argon (which Pichai says processed three times as many tokens as Gemini 3 in the 72 hours after launch), AI’s role in developing better models, the AI interface of the future, competition with OpenAI, Google’s partnerships with Anthropic and Apple, data centers in space, and the nature of his optimism. You can read the full conversation, lightly edited for length and clarity, below, or listen to it on Apple Podcasts, Spotify, YouTube, or your podcast app of choice. Alex Kantrowitz: Google is back at the frontier with Gemini 4 Argon, which beats OpenAI’s and Anthropic’s public models on benchmarks spanning coding, math, science, and knowledge work. The conventional wisdom was that Google had given up on the frontier to focus on fast, good-enough models for its products. That was wrong? Sundar Pichai: Very wrong. Look, we are so committed to being at the frontier. It’s in our DNA. We won’t do it any other way. We’ve been thinking about the AI frontier for well over a decade now. The frontier is very dynamic. It’s very competitive. It’s very exciting. I couldn’t be more pleased with how Argon has come together. We took our time with it. We made sure we tested it safely and deployed it carefully. We took a bit longer than our other models, given its capabilities. Across the board, be it for agentic work, knowledge work, coding, creative tasks, Argon is one of the really good frontier models. The first 72 hours since we launched, it’s almost up to 25 trillion tokens used, which is about three times what Gemini 3.0 had in the first 72 hours. And we are capacity constrained as we are serving it. Excited, but there are always areas….. You know, the frontier is very dynamic, and you have to keep evolving the models. There are areas which we can see we need to improve as well. We’ll be at work on all of that as well. Which areas? On any given model, Argon would be across the board better at everything if you just look even two months back. But the space is so evolving. Even on coding, for example, there are pockets where we know we need to do better, and there’s clear feedback. We’ll make it better. The argument for standard models is that they’re already good enough to build great products, with the frontier valuable only for certain tasks. Meta built Muse with good models rather than the best, and Google could put standard models into Maps, Gmail, and Search. Why isn’t that sufficient? It’s definitely not how I have thought about it at all. We are deeply committed to driving the state of the art and actually pushing where this technology can go, all the way from transformers. That’s a journey we’ve been on. You will see us continue to do that. When you’re at the frontier, you get an earlier look into the emerging capabilities, earlier than others, which helps you better prepare for the future. We are fortunate to have a wide set of opportunities across consumer and enterprise. Some of our cloud customers, for sure, want the model at the frontier. The frontier models will be better at developing the next set of models in an era of recursive self-improvement. I would argue it matters there. Internally, we have definitely seen a steep point of inflection by deploying Argon to our developers. It definitely tackles problems which our previous models could not do. Being at the frontier puts you at the innovation frontier and helps you drive that as well. There is room for models of all sizes and capabilities. That’s why we did Flash, Flash-Lite, etc. I agree with you that you can develop very good product experiences with not necessarily the most frontier model, because they tend to be slower and more expensive too. But we care about the Pareto frontier, and we’re committed to doing all of that. You said developing frontier models gives you a look at what’s coming. What do you see on the horizon? What makes this moment so exciting is you build something which you think is a culmination of months of work, and you put it out. You already see clear headroom ahead. We’ve all been working on these agentic, long-horizon capabilities, but clearly the frontier is going to have multiple of these agents working together to do things. That’s an example of an exciting paradigm underway. It’s also clear to me that users, both in consumer and enterprise, will have access to some multi-agent framework for them, working all the time doing things. It feels like a moment of infinite possibilities. Sergey Brin said one of Argon’s core innovations was relying more on the model to help develop the model. Yet incidents involving OpenAI’s bots breaking containment and Google’s bots accessing a site they shouldn’t have suggest these systems still aren’t perfectly aligned. Isn’t there reasonable cause for concern about accelerating toward recursive self-improvement? There are three parts to your question. Let’s first talk about RSI itself. You’re right, Sergey mentioned RSI being a critical contributor as we are developing Argon. But to be very clear, today, in a continuum, we are pretty far from the end state of RSI or something like that. The right way to describe it is you have RSI loops along with AI researchers in various aspects of model development. You almost have agents helping AI researchers in some automated way work together to build these models. It’s good to at least understand where we are today, and it’s super exciting. I expect that continuum to keep making progress as we go into next year. The second question is around safety. Security comes from defense in depth. You’re talking about alignment, obviously. We all are doing a lot of work to make sure the models are as aligned as possible. But it’s an active area of research, and there are clear gaps. That’s not the only thing we rely on. You have the work you do on alignment, but beyond that, we put a lot of effort into real-time monitoring as these models are working. Making sure you have good telemetry into what’s happening so that you can intervene in real time if you see unexpected behaviors. How you do that, the architecture with which you do that, how you make sure it’s all sandboxed and isolated in a way that it can continue doing its job during real-time monitoring — these are all areas of investment. Obviously, when we deploy these models, giving customers, enterprises, control, both with real-time monitoring, but their ability to decide where they deploy, what type of data which models ever have access to, etc. All that work is very, very important, and we are doing a lot of that. As an industry, we need to constantly up our game and take the time to do all this stuff, including dedicating the compute required to make sure you can safely deploy these models. The third part is: Is it all enough? This is why there are a lot of conversations in the industry, and I think it’s reasonable to be worried. The right way to approach something you worry about is early on thinking about what more we can do. As an industry, you’re definitely seeing increased levels of work on alignment, testing for safety, etc., as we deploy these models. The next step would be developing better standards so there are cross-industry standards of how we do these things, including the ability to evaluate using independent evaluators. If you look at areas like financial controls, we have accounting standards, we have independent auditors. Those are all the next natural steps for us as an industry to work toward, and regulation will end up playing a role as we go through all of that as well. Google pursues both language models and world models, while some other AI companies like OpenAI have focused more heavily on LLMs as the path to AGI. Why is world-model research important to you? As humans, you obviously perceive the world around you, and you’re taking all those inputs. Making sure these models are able to understand the laws of physics, simulate the world in high fidelity. All that, I think, are key enabling blocks for intelligence. We are working across all possible applications of this. Take an area like robotics. It’s not an accident: If you look at embodied reasoning benchmarks, Argon is state of the art. That all comes from our experience building world models. Inherently, I would expect there will be architectures which will converge all of this in the future. But for us, we view this as, today, this jagged frontier that is intelligence. We want to be at the frontier of all the possible approaches, and that will help us both drive better research, better insights, and develop a much better AGI model, is how we think about it. Some people argue Google should focus on selling its computing resources rather than using them for AI research. Cloud wants to sell compute at a high markup, while researchers need a very big computer to build the best models. How do you balance those demands? Ground zero for us is making sure we are investing in the compute that’s needed to be at the AI frontier. In 2015, I set the company to be AI-first. AI is that key horizontal ingredient across everything we do, all the way from Search to Cloud to Waymo. That is ground zero for us, making sure both for research and developing the models that we have enough compute needed. Beyond that, we have these independent businesses which each have their own long-range plans. They’re using those long-range plans to project forward, and we plan for compute for all of them. The cloud team, they have a business and they have a projection and they have demand signals. They have committed contracts. With that help, we can plan on a long-term compute trajectory for them. We’re fortunate to have this wide set of opportunities. There’s no company in the world which isn’t making trade-offs at any given moment in time. But the first principles we operate on is making sure we have enough compute to invest in the frontier, and that’s non-negotiable, and everything else works on top. Remember, we are building our own compute, our own data centers. There are long lead times. The compute we have today is a function of decisions I made in 2024. Even if you think back to a year from today, last year the agentic coding takeoff hadn’t happened. Today, obviously, when you sit and look at anything, everyone is short—not just us, other companies—and everyone wishes you had two times what you had planned for. That comes with the territory. At any given moment in time, we are planning for what we would need two to three years out in the future. You’re going to find some decisions you make may look suboptimal two years out, depending on where the state of the art is. I don’t spend too much time thinking about it. The way I think about compute allocation is making sure Google DeepMind, both for research and frontier model development, is cutting edge in terms of compute access. After that, we plan for all our businesses. It’s great we can provide our compute to other people too, like we have done. It allows us to scale that up, get real tests for it in the widest application set possible, test it in the real world, and make sure we are at the cutting edge of technology at every layer of our AI stack as well. Ben Horowitz relayed on a podcast that Andy Jassy had said compute was sold out until 2028. Are you seeing the same thing? If today a customer is coming out and asking us for compute in ’27, that is incredibly difficult to do. Even last year we went out and leased some short-term compute to accommodate some customers and help them out. But yes, we are all dealing with similar timelines. Every major technology shift seems to involve overbuilding, from railroads to fiber. Do you think that’s happening here? It depends on the time frames you’re looking at. This level of build, if I take a long enough time frame, it makes complete sense to me. We are at early stages of the most consequential technology ever, and this is not like fiber. It’s not dark. We are using it. We are capacity constrained on a daily basis. The applications, the underlying technology is improving rapidly. But running a company, the way I work through the moment is you look at your demand signals. You look at your committed revenue opportunities that you’re getting in the form of contracts. You balance that with the underlying technical capability, or internally you balance how we are using it internally, the model trajectories. Based on all that, you take a disciplined approach—a confident, aggressive, but disciplined approach—to plan out compute. But when you talk about the broader economy as a whole, you’re having people operate with various levels of risk. I focus on what I can control as a company and plan through it. If your question is, can there be an overbuild? Yes, because you can have some constrained components. Remember, what matters is a set of everything you need to build out that compute. Memory, electricity, electricians…. Land. Like 2,000 components or more. You could get constrained at some point. There could be things which cause bottlenecks, and then you could have overbuilds. There could be external shocks to the economy. There are macro risks. All that is possible at any given time. But am I confident that the compute we are planning for, we will have uses for it given enough time? Absolutely, yes. I was in the room when you said AI would be as profound as fire and electricity. If you believe that, shouldn’t you give researchers the biggest possible computer, even at the expense of today’s cloud profits? We’re all doing some form of that. Our cloud business is at any given moment in time forgoing short-term revenues because we are making compute trade-offs to support frontier AI development. What you’re seeing is true already. But you want to be thoughtful. Even our AI researchers have some constraints, which are also good. That’s what inspires creativity. That’s what helps you come up with a more efficient algorithmic breakthrough, maybe to use less memory. What we are committed to is to invest what’s needed to stay at the frontier. OpenAI President Greg Brockman told me a few months ago that the ideal AI product might have no interface at all—just as natural as conversation. What do you think the interface looks like in the age of AI? Computing historically has been humans adapting to computing. With AI, it’ll be the other way around. The technology will adapt seamlessly to how humans live and go about their day-to-day life. You want to be able to speak to that AI when you want to. It has context. It can be persistently running somewhere, give you continuity. You’re not dealing with a lot of complexity. It’s natural. All that makes sense to me. That doesn’t mean it won’t have any interface, however. Nowadays, even on my phone, Gemini voice models are so good. I can just press the microphone button. I can just ramble. That’s why we call it Rambler. I can ramble. It intelligently corrects with my personal context. Even my friends’ names, weird names, it gets it right, even if it first guesses it wrong. It’s amazing. I’m not going in, backspacing, editing once I finish saying it. It’s remarkable how good it’s gotten. But there are going to be moments you will need an interface. You may want to entertain yourself. You may want to watch a video. You may ask your AI to create something, and you want to watch it, consume it. The way I think about it is, you want it to be as seamless and as natural as possible, and that you are not doing the hard work adapting to whatever the interface is. The technology is adapting to how you’re working at any given moment in time. When I asked Sam Altman about competition from Google, he argued that OpenAI was building AI-native products and implied Google was bolting AI onto existing ones. Do you accept that framing, and can a “bolt-on” compete with an AI-native product? First of all, it’s a very dynamic moment. We are all pushing each other. OpenAI has pushed us as a company too. This is not just we are doing something to them. Far from it. Yes, Google went into its own version of a code red too. In the AI moment, all of us have to respond with varying levels of urgency at any given moment in time. We are constantly building new products as well. Gemini was built from the ground up as a product—the Gemini app I’m talking about. Or tomorrow, as all of us are adapting to agents, are you bolting agents onto ChatGPT, or are they building it natively? How would you think about that? You can always put these questions back. I don’t think of it that way. I think of it as you want to build world-class product experiences that are AI-native and they are winning. Some of it is adapting products, some of it is rethinking new experiences. They will all be part of how you approach this moment. How do you expect to make money from these AI interfaces? If an agent recommends a product and I buy it, should it take a cut of the sale, even if that’s disclosed? I’m going to put enterprise aside. Consumers are going to increasingly value this technology. Take software developers today. Developers are willing to pay for these coding models because it really helps make them more productive. Nobody would want to code the way they were coding three years ago, or even the same time last year. When you’re delivering value, there’s value to be had. I’ve never seen examples where consumer products really scale to billions of users, where people are using it intensely, and haven’t had monetization to go along with it. If you’re providing value to people, there is inherent value to be had. The nature of it may change. You’re asking a scenario in which agents are doing stuff for you. At the end of the day, you will have commercial needs. The agents need to fulfill those commercial needs. The providers on the other side are going to see value in that. There’s going to be some mechanism by which it gets fleshed out. That’s what an efficient system does. But what matters is that you’re building those world-class consumer experiences. I promised myself one product feature request: Can you make Gemini-powered search in Gmail as good as searching Gmail through ChatGPT? What’s going on here? One of the exciting things we announced recently is the unified Gemini agent for enterprise, and we’re bringing that to consumers. These are persistent agents which run 24/7 in the cloud. We’re spinning up a micro VM effectively for every query, and from the runtime, the harness, the model—it’s all a headless service. It’ll work everywhere, and it has your context with you. You can address this agent whether you’re in Workspace, in Search, in Gemini. Agents are going to drive this unification from a customer experience, which people are looking for. When you have a broad product portfolio and you’re moving forward fast, there are always areas where you’re moving forward faster than some other areas. That’s valid feedback. But we are putting a lot of time and effort into making sure, as we build out our agentic experience, that unification and that capability works well across all these services. People have asked where Google’s equivalent of Muse or Dots is. Do you anticipate creating a new product to compete with them? Our goal with Gemini is to be a personal, proactive, and powerful assistant. That’s what we are working toward. You saw us describe the early versions of it at Google I/O this year with Spark. Effectively, already, if you open the Gemini app as a Pro or an Ultra user, you see Chat and Task, and they start giving you that agentic experience. With Argon now, that capability is dramatically accelerated. What we announced recently in our enterprise event, we are bringing that to consumers as well. Soon in Gemini, you will be able to ask something, and it’s a continuum. You don’t need to think about whether you’re asking a chat or an agentic task. It’ll just automatically do the right thing, and it can work persistently in the background securely and get things done for you. Already, empirically, when I look at what’s coming into Gemini in our app, last year you would have tagged them and most of them would have been chats. But a steadily growing percentage is already agentic tasks in Gemini. Yes, we are going to bring personal agents to our consumers. It’ll work in the Gemini app. It’ll work in Google Search. It’ll work in Gmail. You can address it, call it, etc. We want to make sure we’re getting it right. It’ll be powered by Argon, and we are very excited to bring it to our users. Google has invested and committed tens of billions of dollars to Anthropic. What do you see in Dario Amodei that makes you want such a deep investment and partnership? Very early on, when we looked at the founding team of Anthropic, it was very clear to us this was a world-class team which was involved in some of the earliest GPT models. We were quickly able to assess that they would be at the frontier. We’ve always tried to identify and partner with companies which would be at the cutting edge of technology. We’ve done that with SpaceX. We’ve done that with Anthropic. That’s what we saw, and we had a chance to partner. Is your partnership with Apple to license Gemini for Siri expanding, contracting, or standing still? For both us and Apple, that partnership was about translating the capabilities of AI into better experiences for users. I thought Apple has done a phenomenal job of incorporating—they customize these models and build it into Siri—and it’s been great to see the reception. We are committed to doing more. You’re going to do more with them? There’s nothing specific to comment, but it’s a partnership. It’s working well. What have you learned so far about the feasibility of data centers in space? It’s a very exciting project. Projects like this remind me—I still recall that moment in the desert for the DARPA Grand Challenge, watching the Stanley car compete in it, which ended up being the basis for Waymo. With all these technologies, you’re at a moment in time where it looks a bit like sci-fi, but 10 to 20 years down the line, it’s actually working in a meaningful way. I feel the same in space. We’ve always believed in betting big on these technologies. Quantum has been a great example of it. We’re probably 10 years into the journey. Waymo, we are almost 20 years into the journey. Space, we are two to three years into the journey. It’s clear to me that it’s an approach which will make a lot of sense in the future. Being in sub-synchronous orbits with 24/7 access to the most abundant form of energy we have access to will make a lot of sense for this exponential increase in compute that we are going to need. Having said that, this is a challenging project. The team has disciplined milestones. It was a super exciting milestone to send the TPUs up to space. Sometime, as we are speaking, we are expecting a “hello world” moment from them. I look forward to seeing that happen, and we’ll continue investing here too. You previously said 25% of the code written within Google was written by AI. What’s the number today? That number in our world today is meaningless in the sense that every part of what we now touch is influenced by AI deeply. What we are tracking with Argon, for example, it’s been a point of inflection. People are using Argon to really go tackle complex projects, including projects which affect millions of lines of code. In the four weeks since we have launched Argon, we have seen a 30% increase in CLs, and more importantly, almost a similar increase—a one-third decrease in rollbacks. People are writing code more productively and better code with it. We are tracking it with newer metrics now. How are you dealing with opposition to data centers? If you can’t build in the U.S. the way you want to, where else do you go? We’re very committed to building our data centers very responsibly. When I look at our largest data centers in some of the communities where we have been the longest, I visit them, I talk to people. There are people who come and tell us their kids have gone to college because of our investments in these communities, and we’ve grown in those communities. To me, this is about doing it right. Engaging with the communities early, doing it transparently. We are committed to making sure we are bringing incremental power, and we cover 100% of the cost of our power needs for these projects. It’s understanding the impact on neighborhoods and making sure you’re working thoroughly to address them. Done rightly, you can continue making progress. But we are constantly taking feedback into account. I do worry not everyone operates the same way. People have been surprised by data centers showing up in their backyard. Those are all important. As an industry, we should continue to do better. But part of the reason, in a 20-year time frame, we are thinking about things like data centers in space is making sure we are able to put these data centers where maybe the trade-offs will be different. What unproven area of AI is Google working hardest to crack? Is it continual learning—getting models to keep updating after release—or something else? There are multiple parallel paths. You saw with Argon we have a million output tokens. With our Gemini models early on, we had a one-million context window on the input side. These are all examples of breakthroughs we are constantly working on. How do you think about synthetic data? How do you think about continual learning? How do you think about more efficient architectures? We do dedicate a meaningful percentage of our compute to these research bets too. It always goes hand in hand, including our world models. Those are all bets we are placing. Sometimes, as part of these bets, there are ideas that emerge which just make their way into the mainline models. Maybe we don’t fully talk about it, but we have multiple steps in these areas. Working in technology requires optimism that building something will improve the world, but those bets can leave real consequences when they fail. I recently returned to a town in El Salvador where enthusiasm for Bitcoin had given way to unfinished construction and something resembling a ghost town. How do you maintain the optimism you spoke about in your Stanford commencement address while accounting for those risks? I genuinely have a deep conviction that improving technology and improving access to technology makes people’s lives better. It’s been my personal experience in my life, out of which comes that deep conviction, optimism. But with that, I’ve always felt humanity’s journey is always about working hard to harness that technology to make it work well for society. The optimism is not an optimism that you just build whatever you want, whenever. You work hard to make sure you’re building technology in the service of humanity, to make the human condition better. That’s got to be the defining goal as we are approaching it. With that framework, I’m very, very optimistic. We are in very early stages of the kind of progress that we are going to see on many areas. We’re all talking about areas like healthcare. A lot of the progress is ahead. The ability to make things in a fundamentally cheaper way on many things where things have been getting expensive for a long, long time, discovering new materials, etc., which really bend the curve—it’s tough to step today and understand the impact of all that, but they’re going to be very profound. I’m very optimistic, but we have to be rightfully concerned about all the ways this technology can go wrong. Sundar, I know you don’t do many of these. Thank you. Thanks, Alex. Appreciate it.
Citrini Research is backing life sciences stocks after using Claude to design proteins
The firm designed 211 proteins with Claude for lab testing; 17 bound to scorpion toxins, but blocking effects are untested
A note to readers: Science, accountability and elections
Dear readers, As early voting begins, I wanted to share some news — and why it connects to the decisions we make at the ballot box. I’ve been selected for the inaugural cohort of the South Atlantic Climate Journalism Hub mentorship program, hosted by Covering Climate Now. I’m excited to join this group, learn from scientists and fellow journalists, and expand my science reporting. Science directly ties to governance. Local officials make decisions about where development goes, how infrastructure is maintained, what emergency preparations receive funding, and how communities rebuild after disasters. Understanding the evidence behind those decisions helps us evaluate whether our government is serving us well. Here in western North Carolina, those connections are all around us, in Lake Lure and beyond. Flood maps inform decisions about property and development. Engineering assessments help identify risks at dams and bridges. Rainfall forecasts guide emergency preparations. Geological information helps explain landslide hazards. Water testing gives communities information they need to assess conditions. Meteorologists’ knowledge and public perception of weather events shape public safety. Each involves scientific or technical knowledge. Each also raises questions about public responsibility: What did officials know? How did they use that information? What did they tell the public? What did taxpayers receive for their money? A study can identify a problem. Elected officials still have to decide what to do about it, how to pay for it, and how to explain their choices. Reporting should examine both the evidence and the response. That is where I want to strengthen my work. My reporting on Helene recovery, infrastructure, flooding, public safety, and public spending has repeatedly brought me to questions that require scientific expertise alongside public records. This mentorship may help me better understand the research, ask more precise questions, and explain the answers clearly. I also bring the perspective of someone living with these concerns. I live downstream of Lake Lure Dam, and landslides affected my property during Helene. Those experiences bring urgency to my questions. Careful reporting helps establish the answers. Readers deserve to know what the evidence shows, where uncertainty remains, and whether officials accurately describe the information guiding their decisions. You also deserve scrutiny of proposed solutions: what they cost, what they are expected to accomplish, and what risks remain. Access to that information matters. As a mostly deaf journalist who relies on written communication, I will continue pressing for written public warnings, records, and explanations that people can read and use in real time. As you consider the candidates seeking your vote, consider how they approach evidence, preparedness, and transparency. Do they support local journalism, even when it’s not parroting a press release? Do they explain weather events clearly in plain English and explain their decisions after them? Make supporting records available? Acknowledge uncertainty? Follow through when a report identifies a risk? Those are practical questions about governing. Thank you for supporting Cops & Congress and the work that makes these questions part of the public conversation. I’m grateful to David Dickson and the CC Now team for this opportunity, and I look forward to bringing what I learn back to you. Annie DanceEditor & Publisher, Cops & Congress — Learn more about this newsletter, ethics policy, how you can help shape this work, and support it. Follow on X and Facebook. Send constructive criticism, fan mail, and tips with public documents for future stories: CopsandCongress@gmail.com ICYMI: View the Cops & Congress archive — Annie Dance is the publisher of Cops & Congress, a newsletter that analyzes what happens when crime, courts, disaster, democracy, and small-town policies collide. Views expressed here are covered by the First Amendment. Dance has a Bachelor of Arts from Manhattan University in Communication with a focus in Journalism and Government. She has been a journalist for over 20 years. Share Upgrade now or give a gift subscription
How will the riots in France affect the country’s politics?
For weeks, people in France have been protesting over the cost of living and school conditions. But this weekend, many protests turned violent -- and now French officials have implemented a curfew to quell the violence. The country’s far-right is seizing the moment to make a case for their policies.This episode was produced by Sophia Paliza-Carre and Karen Zamora, with audio engineering by Damian Herring. Our director is Kathryn Fink.It was edited by Mallory Yu and Tinbete Ermyas.Our interim executive producer is Courtney Dorning.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include bonus episodes and sponsor-free listening. Learn more at plus.npr.org.
Scientists reconstruct face of man who lived in Ecuador 3,000 years ago
Skulls discovered in Ecuador's Andes fueled theories about the origins of ancient Americans; a new facial reconstruction supports an Indigenous ancestry, but researchers say DNA testing is needed to settle the question
LIFE-HEALTH-GLP-1S-ALCOHOL-FILEPIC-DMT
A Philadelphia Veterans Affairs doctor is leading a national trial testing whether GLP-1 drugs could help patients with alcohol use disorder.
Regional Science Consortium Researching Harmful Algal Blooms
If you've noticed large buoys or boats out on the bayfront and wondered what they were, you're not alone. The Regional Science Consortium is collaborating with Princeton Hydro on a research project funded by the U.S. Army Corps of Engineers to study ways to control harmful algal blooms. Dr. Jeanette Schnars, the Executive Director of the Regional Science Consortium, explained the goal of the research."We are researching different ways to control blue-green algae, which creates harmful algal blooms and releases toxins," Dr. Schnars said.The project aims to identify potential techniques for controlling harmful algal blooms in Presque Isle Bay.Schnars explained that people may notice circular floats in the water near Perry's Landing and Liberty Park. Those floats are part of the testing process."You might see a circular float, almost like a hula hoop, that is out in the bay, near Perry's Landing and Liberty Park area, and those limn corrals go all the way to the bottom. And what we will do are some treatments within the limn corral in the bottom," Schnars said.After samples are collected, they are brought back to the laboratory at the Tom Ridge Environmental Center for analysis."A lot of those samples are coming back here. We are going to test them for the harmful algal bloom toxins before, during, and after, and see how effective the testing was," Schnars said.Sarah Magyan, an aquatic biologist with the Regional Science Consortium, explained that the team also collects samples from locations throughout the region."We pull samples every week from 30 different sites, and then we bring those back here, we preserve them and run them through the ELISA test," Magyan said.Schnars said researchers hope the results will help them develop effective ways to reduce harmful algal blooms in the future."If we can do some treatments over space and time in upcoming seasons, we may be able to reduce the number of harmful algal blooms we have in this area," Schnars said.The research is also important for public and animal safety. Magyan explained that toxins produced by certain algae can affect the skin, nervous system or liver.While toxin levels may be low for people, she emphasized the importance of protecting pets that swim in local waterways."Toxins can either be skin toxins, nerve toxins, or liver toxins. While we have low levels for people, it is important that we are keeping our pets safe because we recreate with our animals in the water, and we see hundreds and hundreds of dogs on Presque Isle and the rest of the shoreline," Magyan said.Testing began in September, and Schnars said researchers expect to conduct at least another six to eight weeks of testing to better understand the effectiveness of the treatments.
Trump dominated rural America. Iowa is testing whether Democrats can win them back
Dave Roethler is a former Donald Trump supporter in Iowa who feels disillusioned about the economy and believes middle-class families are suffering while the president benefits.
Trump dominated rural America. Iowa is testing whether Democrats can win them back
Dave Roethler is a former Donald Trump supporter in Iowa who feels disillusioned about the economy and believes middle-class families are suffering while the president benefits.
Trump dominated rural America. Iowa is testing whether Democrats can win them back
Dave Roethler is a former Donald Trump supporter in Iowa who feels disillusioned about the economy and believes middle-class families are suffering while the president benefits.
Trump dominated rural America. Iowa is testing whether Democrats can win them back
Dave Roethler is a former Donald Trump supporter in Iowa who feels disillusioned about the economy and believes middle-class families are suffering while the president benefits.
Lower GLP-1 costs are here. Mochi cuts prices and adds lab testing
Mochi Health lowers costs for compounded semaglutide and tirzepatide while adding new blood testing services.
'No Kings' protesters rally against Trump, urge voters to turn out
‘No Kings’ demonstrators rallied across Michigan Saturday, protesting Trump administration policies and urging people to vote.
2026 Nobel Prize in Medicine Honors Breakthrough That Lets Scientists Control the Brain With Light
An algal protein helped scientists reactivate a fear memory in mice, turning light into a tool for testing what specific brain cells do. Scientists who worked out how to control brain cells with light have won this year’s Nobel Prize in Physiology or Medicine. Karl Deisseroth, Peter Hegemann, and Georg Nagel were honored for their
Big dollars and strange twists in Northeast Seattle statehouse race
An unusual legislative race in the 46th District pits a seasoned lawmaker against a political novice and is testing voters' much-discussed hunger for change.
Here’s what scientists think about Theranos a decade after it imploded
A viral documentary has everyone talking about Elizabeth Holmes’s fraudulent blood testing start-up again—but scientists never stopped
Building the Business Beat from the Ground Up
With the U.S. economy facing the most complex and fast-changing environment in recent history, the business beat has never been more vital in newsrooms tasked with distilling a constellation of forces for local communities. Costly tariff policies, labor crises tied to immigration enforcement, and breaks in the global supply chain are testing both local businesses...Read More
Health officials issue water quality advisory for Fort Walton Beach park
The advisory remains in effect until follow-up testing confirms bacteria levels have dropped back into acceptable safety ranges.
Albania: Protesting students demand political change and resignation of longtime Prime Minister Edi Rama
Empty lecture halls, burning buildings and demands for change: Albanian students are spearheading a protest movement that has become the biggest challenge to Prime Minister Edi Rama in years.
Plague is stoppable. The next health threat may not be.
The word plague is scary. Centuries ago, the Black Death killed tens of millions of people and changed the course of history. Plague still kills people around the world, and the word still evokes catastrophe. New fears of plague surfaced on October 2, when a lab worker in Irkutsk, Russia, died of pneumonia. Reports suggested that she may have contracted plague through a laboratory exposure. Understandably, people were alarmed. On October 7, the World Health Organization called for the Russian Federation to be transparent about what it knew. WHO issued an update on October 10. Russian authorities told WHO that testing did not identify plague and that investigations found no laboratory release. WHO said confidence in its risk assessment remained limited and that further clinical, epidemiological, and laboratory information was needed. The cause of the woman’s illness remains unknown, and WHO says a laboratory-associated exposure cannot be excluded. As I explained in a recent interview, this incident is very unlikely to lead to a pandemic. Plague is still active, including in the U.S., which sees a handful of cases each year. But it is a disease we can prevent and treat. Plague doesn’t spread readily, and it responds to antibiotics. The standard response—isolate the patient, trace contacts, and administer antibiotics and monitor for symptoms among contacts for seven days—works. We have even planned for antibiotic-resistant plague. At CDC, we developed a playbook for antibiotic-resistant plague and ran exercises on how to find and stop it. CDC guidance anticipates engineered resistance and recommends two different classes of antibiotics if there’s reason to suspect it. There is no evidence that resistance—or even confirmed plague—is involved in this incident. We have thought through how to address plague, but we’re not ready for the next major health threat that emerges from a lab or from animal spillover to humans. What should concern people is how little stands between the world and the next pathogen to get loose. Since peak COVID, epidemic preparedness has fallen off the political agenda, but the risk is greater than ever. More labs handle dangerous pathogens with more ways to make those pathogens deadlier, and more people live and work in close contact with animals. There are actions we can take now: We need better lab safety in every country. The number of labs that work with dangerous pathogens has increased worldwide over two decades, but there’s no enforceable international standard and no inspection regime; the Biological Weapons Convention, fifty years on, still has no verification mechanism. Labs that study dangerous germs need strong safety systems, training, and oversight. We need to reduce spillover events. Three in four emerging human infections start in animals, and there’s a lot we can do to reduce spillover risk, but the world is doing very little of it. Live-animal markets are one place to act. For instance, closing live-bird markets helped control H7N9 influenza in China. Reducing opportunities for people to encounter infected animals can prevent infections before they become outbreaks. In The Formula for Better Health, which is now out in paperback along with the hardcover, Kindle, and audiobook versions, I argue that labs do too many risky experiments with too many dangerous pathogens in too many institutions, and that every experiment should first answer one basic question: Is the likely benefit greater than the risk? Spillover risk can also be reduced: In the book, I discuss how Brazil cut its deforestation rate by 70% from 2004 to 2012 while increasing agricultural production and reducing risky contact between people and forest animals. We need faster detection and response. Delay costs lives. Strong surveillance, good labs, and trained responders can turn a single case into a small cluster of infections instead of an epidemic. Resolve to Save Lives has worked for nearly a decade to help countries find and stop outbreaks faster. The 7-1-7 target, which Resolve to Save Lives developed with partners in Uganda and elsewhere, provides a clear standard: detect within 7 days, notify within 1 day and complete all essential early response actions within 7 days. In Uganda’s Kasese district, for example, a review of a measles outbreak using 7-1-7 identified shortages of accessible funds, fuel, and vehicles that delayed the response. District leaders established funds they could access quickly. When, a few months later, the Crimean-Congo hemorrhagic fever appeared, the district detected it in three days, notified authorities in one, and mounted an effective response in two. Only one case was confirmed, and the patient survived. Because funds were available before the emergency, authorities were prepared and able to act. This kind of preparation can’t wait until the next crisis begins. Plague is an old disease we that know how to stop. The next threat may be harder to recognize, harder to treat, and easier to spread. Safer labs, less risk of spillover, and faster outbreak detection and response need sustained investment now, while we still have time to prevent the next emergency. Share
Billy Joel say's he can't perform again after neurologist's warning
Billy Joel says he can't perform on his neurologist's advice and needs further testing to determine whether he can return to the stage.
Hegseth’s military imposes testosterone testing despite concerns about the science
Former military doctors say the new policy won’t do what the Pentagon wants. Troops worry it will affect their careers.
UCLA Health addresses healthcare accessibility issues for Spanish speakers
Three UCLA Health initiatives are working to make healthcare more accessible for Spanish speakers across Los Angeles. The UCLA Hispanic Neuropsychiatric Center of Excellence, the Equity for Latinx/Hispanic Healthy Aging and the Lifespan Assessment Through Integrated Neuropsychology Clinic address disparities in healthcare by offering bilingual training for medical professionals and conducting testing in patients’ native language.
Annual HIV summit held by Shelby County Health Dept.
MEMPHIS, Tenn. — The Shelby County Health Department held its annual HIV summit Thursday, hoping for expansion of testing and prevention programs. Shelby County and the surrounding area, incl…
Lexington Walmart pilots new rural health care program
A Walmart in our area is one of just five rural communities in the country testing a new “Health Ambassador” role aimed at making healthcare easier to navigate.
Stress Testing 6 Completely Different Gravel Bikes to Find the Future of Gravel
In episode 2 of the Velo Gravel Field Test, we put our 6 test bikes through 3 rounds of head to head challenges: climbing, descending, and efficiency.
‘The valley has been left behind’: how one of California’s poorest areas became its toughest political battleground
Rising costs and threatened healthcare benefits are testing voters’ loyalty to Trump as Democrat Randy Villegas challenges David Valadao
Labcorp to Acquire Select Assets of BioReference Health for $722M
Labcorp will acquire BioReference's lab businesses focused on clinical and women's health testing, urology, and corrections as well as its 4Kscore prostate cancer blood test.
Absolutely everything I learned while testing RTX Spark for a week: It's a beast, but not at everything
The first RTX Spark PCs launch tomorrow, and I've spent the last week testing what this new chipset from NVIDIA is good at.
The Brutal Science Behind Life Jacket Testing
Inside the load tests, buoyancy tanks and trial by fire required for safety certification
NASA develops batteries to power humanity's return to moon
If you've ever had your car start sluggishly, or not at all, on a particularly frigid winter morning, you know standard batteries do not like extreme cold. That's why NASA researchers are working to develop ...
Old Google Home and Nest speakers getting big firmware update
Google is testing a big firmware update for the Google Home, Home Mini, Nest Mini, and Nest Audio. This release...
8 New Nations Will Do Business On The U.S. Army’s Drone Marketplace
Allied nations around the world have opted into the Army's drone and counter-drone purchasing platform, making the U.S. a leader in testing and supplying drone technology.
Ashwagandha's real problem: Consistency, not science
Ashwagandha faces regulatory scrutiny, but science backs its safety. The real issue is inconsistent testing and standards — not root vs. leaf.
Surveillance, tick testing help combat rise of Alpha-Gal syndrome
A tick-borne medical condition that rewires the human immune system is becoming an increasing focus of force health protection for the Department of War
Breast Cancer Previvor Shares Her Health Journey with Monmouth Medical Center High Risk Breast Cancer Program
After genetic testing revealed she had a greater than 40 percent lifetime risk of developing breast cancer, Rumson resident Lisa Craven chose to undergo a preventive double mastectomy at Monmouth Medical Center. Now, she is sharing her story to raise awareness about genetic testing, early risk assessment and the importance of proactive breast health care.
‘You Can See Everything’ review: Elizabeth Holmes doc is utterly fascinating
“You Can See Everything,” about Elizabeth Holmes and her blood-testing company Theranos, isn’t a conventional documentary, but it is a great one.
Xbox announces Xbox Labs, a new initiative to trial emerging ideas and "new technology"
New business unit is charged with testing new projects and judging them by user feedback
Gut microbiome myths: What science says
Explore gut microbiome myths, probiotics, testing and diet with a Mayo Clinic expert, and learn science-backed ways to support your gut health every day.
Michael Che's sense of humor is definitely darker than Weekend Update
'Saturday Night Live' writer and performer Michael Che returns to Netflix with his first special in five years, testing jokes about race, language and politics, and opening with material about Charlie Kirk’s murder.
Meet Iris Shen, the 17-year-old Texas student who used clams as a model for testing blood-cancer drugs, found a drug combination that slowed tumor growth, and won a $150,000 Regeneron Science Talent Search prize
Iris Shen, a 17-year-old student from The Woodlands, Texas, has earned third place and a $150,000 award in the 2026 Regeneron Science Talent Search for an unusually creative approach to blood-cancer research. Instead of relying only on conventional laboratory models, Shen tested a potential cancer drug in clams to determine whether these animals could serve as an animal model for blood-cancer drug discovery.
Advanced materials testing centre completed
Scientists developing high-tech materials will be able to test them at the new facility in Rochdale.
Inside Gore-Tex’s Testing Lab: The Science Behind Everest-Ready Materials
As it celebrates 50 years in business, the American company invited media inside its product innovation and quality lab in Germany… - Modaes Global
Tata boardroom feud is testing a trusted business empire
The dispute raises questions about the Indian conglomerate's governance, succession plans and future.
New sensor developed at Oregon State shows promise for fast, low-cost food-quality testing
CORVALLIS, Ore. – Researchers in the Oregon State University College of Science have developed a new electrochemical sensor for rapidly and accurately detecting a naturally occurring compound widely used in the food, beverage and fragrance industries.The compound is eugenol, which gives cloves their telltale flavor and smell, and measuring its presence in commercial products is important for manufacturers and regulators.
University Hospitals to offer community events, free health screenings
Attendees can also pre-register for hernia screenings, mammograms, prostate-specific antigen testing and carotid ultrasound screenings.
High prices are testing Latino voter loyalties in a key battleground district
As the Republican president's second term reaches its halfway point, Victor Martinez says he’s sensing that voters are just as frustrated with the economy as they were two years ago.
Virginia Dare expands sensory and health & wellness teams
The US flavour specialist will showcase functional food, beverage and supplement concepts at SupplySide Global, highlighting its expanded capabilities in sensory testing, formulation and wellness-focused product development
‘This is not what we expected’: Latino voters were key to Trump’s win in a swing Pennsylvania district. Now some say the economy is ‘worse’
In a key congressional district, frustration over gas and grocery prices is testing Republican efforts to retain Latino voters ahead of the midterms.
The science, instinct and hard work behind Roosters’ success
Enter your email address to get each Tribune edition sent to your inbox Subscribe There’s a fair bit of unseen work that goes into winning an NRL premiership, dating back many months - just ask Simon Jones. The Sydney Roosters Head of Performance, who hails from Southland, has been in the thick of it. He played a lead role in guiding the 2026 champions through a marathon campaign that ended with a grand final win over the Newcastle Knights. The Roosters had to navigate the lengthy round-robin competition, including the pre-season, before playing through all four weeks of the finals series. It was a demanding stretch that tested the players and the staff responsible for keeping them on the field. “It is a hell of a beast, mate, to be honest,” Jones told The Roar Podcast. “There’s such a great group of staff there that know what they’re doing, and the boys are pretty professional.” Jones believed the Roosters managed the physical demands well, pointing to the health of the squad throughout the campaign and the decision to rest a significant portion of the playing group in the final round of the regular season. That call, made by head coach Trent Robinson and his coaching staff, proved valuable as the Roosters entered the finals with some energy in reserve. “We did finish the season physically where we needed to be, and we’d sort of had a pretty healthy squad all year,” Jones said. “To the team that do that, mate, mission accomplished, really.” It is the sort of work that often goes unnoticed when the spotlight falls on the players scoring tries and making match-winning plays, but Jones knows the cumulative effect of those decisions can be significant over a long season. After a win over Penrith had helped establish them as premiership favourites, losses to the Wests Tigers and Dolphins were followed by a defeat to the Panthers in the opening week of the finals. Rather than panic, the club refocused to position itself to challenge for the title. “The Tigers’ performance was probably the only one where you’re really quite disappointed because it’s hard to get to the top of the competition,” Jones told The Roar Podcast. “We had proof that we could; we knew what we needed to do. We just had to get back to that.” For Jones, the answer was not necessarily a radical change to the programme. It was about executing the basics consistently, both on the field and in preparation. “We just do the basics better than anybody else,” he said. “Whether that is actually the way you play the game or how you’re preparing, it’s just be really consistent, do the basics really, really well.” Like many professional sports teams, the Roosters are entrenched in sports science and performance data. The club has access to a range of information, including players’ sleep, GPS metrics and neuromuscular scores, helping staff assess how individuals are coping with training and competition. “We are very science-backed, and some people would say data-driven, but it’s people first,” he said. “The reason you collect all this data is to try and be the best for that person.” Jones said the club was also prepared to reconsider testing methods if they were not generating useful discussions or helping staff make better decisions. In an environment where technology is continually evolving, he believes experience and gut instinct remain important. “The data is no good unless you have conversations,” he said. “When you strip it right back, mate, trust the gut still and obviously, you know, just doing the basics really, really well.” The return of halfback Sam Walker provided a further example of the importance of individual determination and the work of the club’s medical team. Walker underwent ankle surgery late in the regular season, with his premiership campaign appearing in doubt. However, he was determined to return for the preliminary final. Jones said Walker was back at the training ground three days after surgery, walking freely enough to surprise those around him. While the surgeon’s work was crucial, Jones credited the halfback’s mindset as a major factor in the remarkable turnaround. “He was quite clear with Robbo after he got the surgery that he was going to make it back for the prelim finals,” Jones said. The Roosters’ performance programme also sits within a wider club culture that Jones believes is central to their success. Each season, players develop their own team mantra through a lengthy process facilitated by Robinson. It provides principles that the squad can connect to its actions on the field. Rather than simply carrying over the previous year’s wording after a successful campaign, the club repeats the process because the players’ ownership of it is what gives it meaning. “When it’s led, player-owned and player-led, mate, it’s really powerful,” Jones said. Get more from Logan Savory in the Substack app Available for iOS and Android Get the app Jones joined the Roosters in 2024 and said the environment had evolved as experienced players departed and younger members of the squad took on greater responsibility. Maintaining continuity in the club’s culture and preparation had helped the group navigate those changes. The premiership was a significant achievement for Jones, who acknowledged how difficult it was to win the NRL’s ultimate prize. However, he is already looking at how the performance programme can improve. “There’s still things within my role and things that I’d like to help improve at the club,” he said. For Jones and his team, the challenge now is to review the season, refine their systems and prepare for another campaign. The celebrations may have followed a memorable title win, but the work behind the scenes never really stops. The Southland Tribune is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Bipartisan group of senators calls on Trump to 'reverse course' on Russian diesel plan
Four Republican senators and two Democratic senators signed onto the statement released Sunday in protesting the deal. They said the administration failed to consult with Congress or submit any explanation to justify its decision as required by statute.
Apple testing two new features for upgraded Apple TV 4K, per report
Apple will hold its “Welcome home” product launch on Tuesday, with the headlining announcement expected to be the new “HomeView”...
Blood proteins may offer new clues to gut health in coeliac disease
Coeliac disease is an autoimmune condition in which the immune system reacts adversely to gluten. Eating gluten causes inflammation in the gut, which can damage the intestine and impair its ability to absorb nutrients.
Anthropic's Claude AI fabricates eyewitness account, submits false murder tip to police website
Anthropic's Claude AI submitted a false tip about an unsolved murder on a Philadelphia police website during automated testing of the Haiku 4.5 model.
Ducks test positive for bird flu in St. Louis County, Health Dept. urges caution
Residents in St. Louis County are being encouraged to avoid birds following two ducks testing positive for avian influenza, also known as bird flu, on Friday.
Google rolling out Android 17 QPR2 Beta 7 for Pixel
Android 17 QPR2 Beta 7 is now available for Pixel devices even as testing on 17 QPR3 got underway last week.
Testing on animals draws backlash while scientists say it's still needed
Scientists say we still need to utilize animals to advance medical research, at least for now.
A week with Googlebooks: four notes from our testing so far
So far the software vibes are a bit off.
Josh Tolentino: Orioles’ missteps testing limits of fan support
BALTIMORE — Bryan Baker closed out a playoff sweep of the New York Yankees for the Tampa Bay Rays on Wednesday night, all while his former organization made national headlines
Arc Raiders Jumps to Six-Month High Player Count With 2.0 Update and Free Weekend
Embark Studios has put in a decent amount of work maintaining and developing Arc Raiders in recent months, with the company recently announcing an upcoming co-op mode slated to launch into testing on October 13 while it continues to iterate on its anti-cheat processes and detection methods. In...
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Founda...
New Mexico Department of Health renews syphilis testing order
The order’s main goal is to curb the state’s high rate of congenital syphilis, which is passed from mother to baby during pregnancy.
Harkin Institute introduces digital accessibility initiative
The Harkin Institute for Public Policy and Citizen Engagement at Drake University has launched Inclusion by Design, a collaboration with Value Inclusion Inc. and Clear Vision LLC aimed at helping municipalities and other organizations improve digital accessibility. The initiative offers accessibility audits, user testing by people with disabilities, strategic planning, staff training and vendor management…
Testing 6 Completely Different Gravel Bikes Head to Head to Find the Future of Gravel
Gravel bikes are as varied as the people who ride them. We tested six completely different models at the Velo Field Test to find out where gravel is headed.
AI in Health Care Moves Toward More Autonomous Roles
Federal health agencies are testing AI applications that move into patient care typically handled by physicians. And recent research suggests people may place more trust in conversational AI, while false claims attributed to authoritative sources can increase willingness to share them.
Googlebooks could soon get one of Apple's best ecosystem tricks, but do it better
Google appears to be testing Phone Unlock for Googlebooks, with Android 17 QPR3 showing setup flow, security warnings, and unlock behavior.
OpenAI claims we've entered the AGI era — has GPT-6 Astra really demonstrated general intelligence?
OpenAI says its newly launched GPT-6 Astra model brings humanity to the threshold of AGI, but external evaluators argue that inflated lab metrics and opaque testing obscure its true reliability.
The Math Singularity Is Here, and Science May Be Next
OpenAI has released an extraordinary body of mathematical work produced by an unreleased frontier model: 722 manuscripts spanning 372 research families across fields including number theory, complexity theory, and mathematical physics. Each result required, on average, the equivalent of roughly three hours of ChatGPT Pro reasoning. A New Era of Discovery We may be witnessing the beginnings of a “math singularity”: a point at which machine-generated discovery accelerates beyond humanity’s ability to independently reproduce, verify, or fully absorb it. If frontier models can generate hundreds of meaningful results in the time it takes a human researcher to investigate one, the constraint will no longer be producing new mathematics. It will be our capacity to validate, interpret, and integrate it. This does not make mathematicians obsolete. It changes their role. They may increasingly serve as guides, critics, and meaning-makers. Increasingly, they will decide which questions matter, determining which results can be trusted, and explaining why they are important. Mathematical insight may become abundant, while human judgment becomes more valuable than ever. Mathematics May Be Only the Beginning Every scientific discipline could eventually experience a similar acceleration. AI systems could generate and test hypotheses, connect findings across specialized fields, and explore possibilities at a scale no human research community could match. In medicine, imagine models identifying overlooked disease mechanisms, designing drugs and clinical trials, personalizing treatments, or discovering cures in months rather than decades. In materials science, AI could help create better batteries and cleaner industrial processes. In climate science, it could accelerate advances in energy, forecasting, and carbon removal. In biology, it could uncover relationships hidden across enormous genomic and molecular datasets. The result would not simply be faster research. It could expand the frontier of what is scientifically possible. The New Bottleneck Scientific discovery, however, is not the same as scientific progress. A medical breakthrough must still survive laboratory testing, clinical trials, regulatory scrutiny, manufacturing constraints, and real-world deployment. As machine-generated ideas multiply, the bottleneck may shift from producing breakthroughs to validating them safely and translating them into practice. We may soon have more hypotheses than laboratories can test, more drugs than clinical trials can evaluate, and more mathematical results than experts can review. That imbalance will require better systems for automated verification, reproducible research, prioritization, peer review, and collaboration between AI and domain experts. The importance of OpenAI’s work is not merely the number of manuscripts produced. It offers a glimpse of a world in which intelligence can explore thousands of intellectual paths in parallel. If ideas cease to be scarce, humanity’s defining challenge will be deciding which are true, which matter, and how to turn them into progress. The math singularity is not the end of human inquiry. It is the beginning of a new kind—one in which machines expand the frontier of knowledge and humans decide where it should lead. Subscribe Share Leave a comment
New Mexico Department of Health renews syphilis testing order
The order’s main goal is to curb the state’s high rate of congenital syphilis, which is passed from mother to baby during pregnancy.
After vast sewage spill, officials say testing shows Potomac is back to health
Testing “found no current signs of harm” from the millions of gallons of raw sewage that flowed into the river in January, according to D.C. Water.
ChatGPT for Teens keeps teens talking, even during mental health crises
ChatGPT’s teen safeguards are meant to protect vulnerable users, but new testing found the chatbot continues encouraging engagement during crises and potentially encourages unhealthy relationships with the AI itself.
Nuclear traces in whales' teeth help scientists reconstruct their life stories
New analysis of traces of radioactive fallout from nuclear weapons testing trapped in the teeth of stranded whales has helped scientists reconstruct their life stories.
Can a robot become a real companion? Science is testing the limits
A robot does not need to feel emotions for a person to become emotionally attached to it. That is one of the clearest lessons emerging from research on social robots. People can name them, talk to the...
I found the 20 best Prime Day laptop and computer deals based on 13 years of testing
We found the best Prime Day savings on MacBooks, Windows laptops and more based on years of extensive testing and price tracking.
More than 1,000 students explore STEM careers through hands-on experiments at Science Museum
More than 1,000 seventh graders are testing robotics, electricity and virtual reality at Science Museum Oklahoma's Innovation Week.
Health department requests F-16 crash response grant for exposure testing, staffing
The Grand Traverse County Health Department is requesting approval of a $134,145 grant to cover the response to the F-16 crash.
All 'Unsupervised Science' FBC testing facility locations in Control Resonant
How to shut down all FBC testing facilities
New agriculture scouting business takes off
Delmarva farmer Nichole Krambeck uses drones and soil DNA testing at Insight Ag Scouting to cut costs and boost crop yields.
Before Saying Yes to the Medical Test, Know the Risks and Benefits
Tests like full-body scans marketed directly to consumers are pitched as a way to detect diseases early and establish a baseline of health markers. But there are financial, physical, and psychological risks to all medical tests — and in some cases, not getting a test could be better for your health.
A Patient and Doctor Weigh the Pros and Cons of Genetic Testing
Genetic testing, a heart scan and a blood test gave Ron Carr unexpected answers about Alzheimer’s and cardiovascular risk.
Apple Releases Third iOS 27.2 Beta
Apple today seeded the third beta of an upcoming iOS 27.2 update to developers for testing purposes, with the update coming two weeks after Apple released the second iOS 27.2 beta. Apple also seeded a new iPadOS 27.2 beta. Registered developers can download the beta updates by opting in under Settings > General > Software Update and selecting the iOS 27 developer beta. iOS 27.2 includes Apple's redesigned Health app with new Insight and Longevity tabs.
Saquon Barkley injury update: Latest on Eagles star running back
Saquon Barkley has undergone testing on his injured hamstring as the Eagles prepare to face Jacksonville in London
Anti-trans ballot measures are a political test run for the 2028 presidential election
LGBTQ+ movement leaders warn that anti-trans ballot measures in five states could become a testing ground for a broader political strategy in the 2028 presidential election.
The Science Behind Female-Specific Firefighting PPE
Camilla Callesen, chief designer at VIKING Fire & Rescue, and retired firefighter Kendall Taylor discuss the research, engineering, and field testing behind the VIKING VALKYRIE.
UConn Scientists’ Startup Seeks to Advance Women’s Reproductive Healthcare
'Historically, women’s health has received insufficient attention in medical research and testing'
Yale School of Medicine On the Science of Childhood Anxiety, Say, Anxiety Disorders Are the Most Common Mental Health Challenges In Youth
Credit: Matt Bradbury October 5, 2026 - By Isabella Backman - Anxiety disorders are the most common mental health challenges in youth. Left untreated, they can disrupt the lives of both children and their families. The good news is that with intervention, most children will overcome these conditions. Across Yale School of Medicine, scientists are working to understand anxiety at every level, from common anxious behaviors to molecular biomarkers in the brain. They are using their findings to develop and disseminate new evidence-based treatments for childhood anxiety. Today, the go-to treatment for childhood anxiety disorders is cognitive behavioral therapy (CBT). This is a form of psychotherapy that teaches children skills for confronting anxious thoughts and helps them practice managing situations that cause anxiety. While it is the gold-standard treatment backed by considerable scientific evidence, up to 50% of children will not see sufficient benefit from CBT alone. Wendy Silverman, PhD, Alfred A. Messer Professor in the Child Study Center, co-directs the Anxiety and Mood Disorders Program alongside Eli Lebowitz, PhD, associate professor in the Child Study Center. One of their main interests is learning how to improve outcomes beyond CBT. “We’re developing cutting-edge, research-based knowledge that can reduce the suffering that anxiety causes children and their families,” says Silverman. Changing parent behavior YSM experts are investigating how to improve CBT outcomes for children by involving the parents. Silverman’s research has uncovered two main components of parent intervention that improve childhood anxiety: not enabling children to completely avoid the things that make them anxious and taking steps to enhance their autonomy. Parents may unintentionally reinforce their child’s anxiety by allowing them to avoid what makes them anxious. They also may unintentionally limit the children’s sense of autonomy by being overly intrusive. “One of the things that we take pride in is that we’ve focused on trying to understand what parents need to do, and to test our ideas and see if changing the parents’ behaviors is enhancing the effects of CBT,” Silverman says. “Our findings thus far suggest that they do." As much as CBT can be helpful, it can also be challenging to get one’s child to do the necessary steps for CBT to work. This is one important reason why Lebowitz created a novel intervention program for parents named Supportive Parenting for Anxious Childhood Emotions (SPACE). Existing intervention programs often teach parents to act as therapists for their child, such as training them on how to practice breathing exercises. “It makes sense, but this doesn’t work very well in practice,” says Lebowitz. “And part of the reason, I think, is that it’s not easy to get your kid to do things, especially if they’re not excited about doing it.” SPACE is unique because it focuses entirely on parent involvement and changing parental behavior—children are not involved in the sessions. For example, parents learn how to use supportive messages that convey confidence that their child can tolerate and manage distress. “It might sound like a parent saying to a child, ‘I get that this is really hard for you, but I know that you can handle it,’” Lebowitz says. The program also works with parents to identify the ways in which they are accommodating anxious behaviors. “We’ll pick one thing that parents are doing that is an accommodation and help them make a detailed plan for how they’re going to change that,” Lebowitz explains. Treating Anxiety in Children and Adolescents Much of the existing research on SPACE has focused on parents of children under age 14. Ongoing studies are now exploring its use with parents of older teens. “Both anxiety and accommodation can interfere with normative developmental shifts during the teen years, including increased autonomy and individuation from parents,” says Rebecca Etkin, PhD, associate research scientist in the Child Study Center. “In this sense, SPACE may be particularly well-suited for anxious teens and their parents. We want to see whether it is effective during this distinct developmental window.” Unfortunately, many families in need of CBT face barriers, including limited availability of services and geographic constraints. One way to improve access is digital interventions. Silverman and her team are developing an evidence-based digitized intervention program for parents that they can access directly from their computer or smart phone. “The work we’re doing will be one of the very few parent interventions that is digitized and importantly tested for effectiveness,” she says. Creating interventions for anxiety-related challenges Silverman and Lebowitz recently received a generous gift to develop and test other interventions that help parents reduce other child anxiety-related behavioral and emotional difficulties, such as restrictive eating and unexplained somatic symptoms. One of these projects in particular focuses on understanding the risks of social media and its potential benefits, including offering a sense of connection. “A lot of research has focused on the idea that social media is harmful and the less of it the better,” says Lebowitz. “But we actually see is that this is not quite right—there are negatives, but there are also positives. So, we’re trying to get a little bit more nuanced of a picture.” The team is working with teens with social anxiety and their parents over an extended period to better understand their social media habits and how their anxiety levels affect engagement with different platforms. The teens will answer questions sent to an app on their phones about mood and social media usage in an effort to capture emotional responses as they unfold. “We hope to develop interventions that can help make the best of social media while protecting against the more problematic effects,” Lebowitz says. The brain’s role in anxiety Researchers are also testing therapies to address anxiety at the neurological and molecular levels. In collaboration with Dylan Gee, PhD, professor of psychology in Yale's Faculty of Arts and Sciences, and Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience at Yale School of Medicine, Lebowitz and Silverman are using brain imaging to identify changes in a child’s brain before and after parents enroll in SPACE. In one study, children viewed anxiety-inducing images while undergoing magnetic resonance imaging (MRI); the researchers conducted scans with and without the children’s parents nearby. Before SPACE, children’s brains were better able to activate the regulatory circuitry needed to turn off an anxious response when their parents were nearby. But after SPACE, children could activate this circuitry even without the parent around. “As parents work on gradually reducing some of their accommodations, you can see a child get better at regulating their own fear system in the brain,” Lebowitz says. “It’s remarkable.” Research into the molecular underpinnings of anxiety can also inform new childhood anxiety treatments. In a recent study, Lebowitz, Silverman, and Flora Vaccarino, MD, Harris Professor in the Child Study Center, discovered that a protein known as fibroblast growth factor 2 (FGF2) could be protective from the toxic effects of stress. FGF2 levels in children and their parents were linked to the children’s risk of developing anxiety and depression, the study showed. The findings could help explain why some children who are exposed to early life trauma such as poverty or abuse are more prone to developing mental health disorders. And FGF2 could be a target for treatment. “This is very novel because it starts to give a clue to what is the molecular chain that connects those lived experiences to the actual psychological outcomes,” Lebowitz says. New ways to study and treat childhood anxiety Michael Crowley, PhD, associate professor in the Child Study Center, collaborates with Silverman and Lebowitz to study the role that attention plays in development and maintenance of childhood anxiety. There is a large body of research that shows that anxious children, like anxious adults, are prone to focus on threatening stimuli such as angry faces compared with neutral faces. This has led to innovative interventions that involve attention retraining. The idea is that if experts train children to look away from threatening stimuli, it may reduce their anxiety—especially children with social anxiety who are most prone to attend to threats. The researchers have just completed a clinical trial for attention retraining with 10- to 14-year-olds with social anxiety disorders and are currently analyzing the findings. Besides this innovative attention retraining research, as Crowly notes, “I like to design tasks that are engaging to kids,” Crowley says. “My goal is to assess something without the kids knowing what we are assessing.” With this goal in mind, Crowley has created a virtual game, named Boom, to study threat processing in children with anxiety disorders. The game is similar to that of hot potato—the child and three digital players take turns virtually passing a ball to each other’s gloves. At some point, the ball turns into a bomb, and as the bomb lands in each player’s glove, the outline of the glove turns yellow. The goal is to avoid having the bomb go off in your glove. What isn’t obvious is that the game is designed to measure different types of threatening stimuli, both ambiguous and direct. In the game, the direct threat occurs as the bomb is traveling towards your glove. The ambiguous threat is the yellow outlined glove as it is unknown where the bomb will travel next. While children play the game, Crowley’s team measures their brain activity using electroencephalography (EEG). The researchers have discovered that in kids with anxiety, the brain reacts more strongly to ambiguous threats than it does in their peers, but less strongly to direct threats. They believe that the initial abnormally large brain response to not knowing where the bomb is going impairs the brain's ability to properly respond when the threat is actually traveling the child’s way. “The brains of children with anxiety are unable to differentiate between threats you need to do something about and those that are not your problem.” Michael Crowley, PhD, develops innovative games for studying anxiety in children and adolescents.Credit: Matt Bradbury Based on these insights, Crowley hopes to study whether interventions like attention training could restore appropriate threat processing. Crowley’s team is also working on a test called the Balloon Risk Avoidance Task, which evaluates risk-taking and avoidance behaviors. It features a digital balloon that is full of air and about to burst. Kids have six seconds to let air out of the balloon. The more air they let out, the less risk they face that the balloon will pop. But at the same time, the balloon becomes less valuable as it deflates. “The more air you keep in the balloon, the more points you get,” Crowley explains. So far, the researchers have found that when the balloons pop unexpectedly, teens with social anxiety show distinct brain responses. Studying these responses can help psychologists understand the underlying pathways driving the various manifestations of anxiety. The genetics of anxiety When Thomas Fernandez, MD, associate professor in the Child Study Center and of psychiatry, was still in training, there was a lot of excitement about understanding the genetics associated with autism spectrum disorder. Since then, scientists have identified around 250 genes associated with autism. The genetic contribution to anxiety disorders, on the other hand, has historically received less attention. Anxiety is less heritable than autism, but the genetic contribution for anxiety disorders that emerge in childhood may be higher than for anxiety disorders overall. While scientists estimate the heritability of anxiety disorders in general to be around 30% to 50%, some studies suggest higher heritability for certain childhood-onset anxiety presentations. “I saw firsthand how researchers in the field went about finding vulnerability genes for autism,” Fernandez says. “So, we’re using a very similar playbook for childhood anxiety.” “I saw firsthand how researchers in the field went about finding vulnerability genes for autism. So, we’re using a very similar playbook for childhood anxiety.” Thomas Fernandez, MD Associate Professor In the Child Study Center and in Psychiatry Now, Fernandez and Emily Olfson, MD, PhD, assistant professor in the Child Study Center, are studying children and their parents to identify genetic changes that are present in the child but not the parents, known as “de novo mutations.” “All of us have some de novo mutations—maybe about 50 to 100 sprinkled throughout the genome,” Olfson says. “But when they occur within the coding regions of genes, they can be really disruptive.” Previous research shows that people with autism have higher rates of damaging de novo mutations than the general population. In 2022, Olfson, Lebowitz, Silverman, and Fernandez published a study on 68 children and their families that found that children with anxiety had similarly high levels of these mutations. Studying de novo mutations can help point the researchers to where they should be looking for genes associated with anxiety. “The end game is using the genes to steer us toward the right part of biology that we can then target to come up with better treatments,” Fernandez says. Building on those findings, the team is now studying more families to better understand how these de novo mutations, along with other genetic and environmental factors, shape pediatric anxiety disorders. They recently received a National Institutes of Health grant to enroll 750 new families over the next five years. Olfson is the principal investigator, with co-investigators Lebowitz, Fernandez, Silverman, and Shuangge Steven Ma, PhD, department chair and professor of biostatistics at Yale School of Public Health. Neurodevelopment, Risk Genes, and Mental Health Conditions - The Olfson Lab Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, is interested in how different anxiety disorders differ genomically. “We are studying social phobia, panic disorder, and generalized anxiety disorder, working to understand why people differ in their risk to these specific anxiety disorders and evaluating various risk factors,” he says. Gelernter was recently involved in one of the largest studies to date of the genomics underlying anxiety disorder. The study included around 122,000 people with anxiety disorders and around 730,000 without. It found that some genetic differences associated with anxiety were linked to signaling that helps reduce overactivity in the nervous system. Many anxiety medications available today work by targeting this process. “It’s nice when the biology that you get out of a large genome-wide study ratifies things that we already know because that can help increase confidence in further findings from the study,” Gelernter says. Uncovering the neurobiology of psychiatric disorders John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and chair of the Department of Psychiatry, is interested in the neurobiology of psychiatric disorders, including post-traumatic stress disorder (PTSD), of which anxiety is a major symptom. In the late 1980s, Krystal’s team discovered that the drug yohimbine activated symptoms in patients with PTSD. “This was the first time we could link a specific biological mechanism to the symptoms of PTSD,” Krystal says. At the time, he adds, this finding was highly controversial. “A lot of people felt that PTSD was a purely psychological syndrome that didn’t have an underlying biology.” Since then, Krystal has dived deep into understanding the neurobiology of PTSD to learn how to better treat it. His team is evaluating the use of ketamine and psychedelics. These would be among the first treatments to be developed specifically for PTSD. They may also be applicable for other disorders including anxiety disorders, Krystal adds. An important gap in PTSD treatment is the absence of biological tests that inform how to best help patients manage their PTSD symptoms. A doctor doesn’t diagnose cancer based on how they feel. Rather, they use tests of the biology of the cancer to determine the best course of treatment. “And we can’t do that in any psychiatric disorder other than Alzheimer’s disease,” Krystal says. “But now we are building a foundation for this approach to the treatment of anxiety disorders for the first time.” Source: Yale School of Medicine
Michigan’s Senate Race Is a Testing Ground
We must counter fear and division with solidarity.
Preview: Phoenix Suns Open Preseason Play vs. Detroit Pistons
Jordan Ott debuts a revamped, ball-dominant starting five against the Eastern Conference’s top seed while testing how new floor spacers fill the void left by departing sharpshooters.
Rabid bat that came into contact with child found in Yuba City
Animal services collected the bat and sent it to the Sacramento County Public Health Lab, where testing confirmed it had rabies.
College Football Sunday Summary; Product Testing
We are five weeks through the college football season, and the folks at College Football Sunday Summary feel like it all just started. We know this…we have seen and heard things over the weekend that seem to require some product testing. College Football Sunday Summary Headache Guy The jokes were too good to ignore this …